Related Experiment Videos
Summary
Third-generation oral cephalosporin Cephroxadine effectively prevents and treats dental infections by inhibiting bacterial cell wall synthesis. This antibiotic demonstrated high efficacy with no adverse effects in 71 patients.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Context:
- Dental infections pose a significant clinical challenge.
- Antibiotic resistance necessitates novel therapeutic agents.
- Oral antibiotics offer patient convenience and compliance.
Purpose:
- To evaluate the efficacy and safety of Cephroxadine in managing dental infections.
- To assess the pharmacokinetic profile and dosage regimen of oral Cephroxadine.
- To determine the spectrum of activity against common dental pathogens.
Summary:
- Cephroxadine, a third-generation oral cephalosporin, inhibits bacterial cell wall synthesis.
- It exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria, including resistant strains.
- Clinical trials demonstrated rapid symptom resolution and high efficacy in 71 patients with dental infections, with a dosage of 500 mg twice daily.
Impact:
- Cephroxadine offers a safe and effective oral treatment option for dental infections.
- Its favorable pharmacokinetic profile supports moderate daily dosing.
- The antibiotic's broad spectrum and efficacy may reduce the need for intravenous therapies.